RFK Jr Just Dropped a Bombshell on Big Pharma Elites
RFK Jr just took dead aim at Big Pharma... and he is NOT messing around. Big Pharma is HORRIFIED and their #1 fear may be about to come true. RFK Jr is now poised to EXPOSE Big Pharma's biggest secret.
Shares Stats
| Shares Outstanding | 2,035,000,000 |
| Shares Float | 2,034,280,000 |
| Shares Short | 26,340,000 |
| Insider Holdings | 7% |
| Institution Holdings | 82.68% |
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
General
| Name | Bristol-Myers Squibb Co |
| Ticker | BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 34,100 |
Highlights
| Analyst Target | 52.40 |
| Market Cap | 88,806,100,000 |
| PE Ratio | 17.60 |
| PEG Ratio | 2.26 |
| EBITDA | 19,114,999,808 |
Financials
| Curr Year EPS Estimate | 6.43 |
| Next Quarter EPS Estimate | 1.69 |
| Profit Margin | 10.58% |
| Operating Margin | 26.11 |
| Return on Assets | 0.08 |
| Return on Equity | 0.29 |
| Revenue | 47.7B |
| Earnings Per Share | 2.49 |
| Revenue Per Share | 23.49 |
| Gross Profit | 35,262,001,152 |
| Quarterly Revenue Growth | 0.01 |
Valuation
| Trailing PE | 17.52 |
| Forward PE | 7.58 |
| Price/Sales (Trailing 12 Mt.) | 1.86 |
| Price/Book (Most Recent Quarter) | 5.34 |
Dividend
Bristol-Myers Squibb Co pays out a dividend of $2.47 per share, with a dividend yield of 5.67%.
BMY's next dividend payment will be made to shareholders on November 3, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Nov 3, 2025 | $0.62 |
| Aug 1, 2025 | $0.62 |
| May 1, 2025 | $0.62 |
| Feb 3, 2025 | $0.62 |
| Nov 1, 2024 | $0.60 |
| Aug 1, 2024 | $0.60 |
| May 1, 2024 | $0.60 |
| Feb 1, 2024 | $0.60 |
Dave Ramsey Doesn't Mess Around With Bitcoin Or Gold, Says 'I Have Three Investments' — Here's What They Are
Personal finance expert Dave Ramsey has long dismissed crypto, gold and single-stock investing, calling them risky distractions — but new research shows that his disciplined mutual fund approach may have cost him market-beating returns.
Billionaire Makes $72 Million On Trilogy Metals Stock—Here's What Else He's Holding
Billionaire hedge fund manager John Paulson has scored extraordinary gains with Trilogy Metals—he's also holding gold miners.
THE LIST is Out - Ad
A covered-up LIST has just been revealed... And it's even more damning than we ever could've imagined. I'm talking about corruption at the highest levels of government... And now they're all FINALLY exposed.
Trump approves Alaska mining road to boost copper, zinc production
WASHINGTON (AP) — President Donald Trump on Monday ordered approval of a proposed 211-mile road through an Alaska wilderness to allow mining of copper, cobalt, gold and other minerals.
Elizabeth Warren Says Tariffs Have Made Housing More Expensive: 'Americans Can't Afford Donald Trump's Housing Market'
Sen. Elizabeth Warren (D-Mass.) slammed President Donald Trump's trade and tariff policies for significantly exacerbating the nation's housing affordability crisis.
RFK Jr Just Dropped a Bombshell on Big Pharma Elites - Ad
RFK Jr just took dead aim at Big Pharma... and he is NOT messing around. Big Pharma is HORRIFIED and their #1 fear may be about to come true. RFK Jr is now poised to EXPOSE Big Pharma's biggest secret.
Trump Ally Laura Loomer Turns on Him Over Qatar Military Base Plan, Calls It a 'Betrayal'
Laura Loomer, a staunch supporter of President Donald Trump, has voiced her dissatisfaction with the president's decision to permit a Qatari air force facility in Idaho.
Silver Nears $50 Amid Inventory Crisis, Outpacing Gold
Silver prices closed last week at multi-year highs, coming within reach of their 2011 peak of $49.95 per ounce.
Indiana Teacher's Son Stumbles on Cancer Breakthrough? - Ad
This ordinary son worked on the Manhattan Project and won a Nobel Prize. But he would eventually create one of the strongest natural cancer solutions known to man. Powerful interests have kept this hidden from cancer patients for decades. But today one brave doctor is finally exposing the truth.
Slovak leader announces a deal with US on a new nuclear reactor
BRATISLAVA, Slovakia (AP) — Slovakia’s populist Prime Minister Robert Fico said Tuesday his government has approved an agreement with the United States to build an additional nuclear reactor.
Ondas Holdings Stock Is Hitting New 52-Week Highs Today: Here's Why
Shares of Ondas Holdings Inc. (NASDAQ: ONDS) are soaring Thursday after the autonomous drone infrastructure company said it placed a significant purchase order.
RFK Jr To Senator: "YOU ARE LYING!" - Ad
At a recent Senate firing squad, RFK Jr boldly stood up to Senator Hassan and declared right to her face, "You are lying!" His fight's getting more intense every day... But the general public still might not be ready for THIS. Either way, this could be the SCARIEST health crisis of our time.
White House Accuses Nobel Committee Of 'Politics Over Peace' After Trump Snubbed For Prize Won By Venezuelan Activist María Corina Machado
The White House criticized the Nobel Committee for what it called a political decision to deny President Donald Trump the Nobel Peace Prize.
Ford CEO's Son opts For Mechanic Career Over College, Asks 'I Don't Know Why I Need To Go To College'
Ford Motor Company's CEO, Jim Farley, shared that his son has chosen to become a mechanic instead of attending college.
What Neil Armstrong REALLY Saw on the Moon [TERRIFYING] - Ad
You won't see THIS in any history book... But after becoming the first man to set foot on the moon... Neil Armstrong reported a strange encounter he had in space during a post-mission debrief. NASA did their best to keep it secret... But now, unearthed NASA audio is blowing the lid off of everything.
Democrats embrace a shutdown fight in a rare moment of unity against Trump
NEW YORK (AP) — On this, at least, the Democrats agree: It's time to fight.
Peter Lynch's Investing Tip: If an 11-Year-Old Doesn't Get It, Maybe You Don't Either
Renowned investor Peter Lynch has reiterated his long-standing belief in the importance of understanding one's investments.
Big Food is ATTACKING RFK Jr - Ad
After announcing a ban on using govt welfare for sugary drinks, Big Food launched an all-out assault on RFK Jr. But it's nothing compared to the fight Big Pharma is likely preparing. RFK Jr is poised to reveal their biggest secret and Big Pharma will stop at nothing to keep it hidden.
4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals
Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.
Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report
Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug portfolio.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Senseonics Tumbles As Q3 Results And Split Hit Stock
Senseonics stock drops on reverse split announcement despite record U.S. patient growth and 91% jump in Q3 revenue.
This New GMO ETF Lets You Bet On America's Industrial Comeback
GMO's new Domestic Resilience ETF (DRES) targets U.S. companies set to benefit from reshoring, energy, defense and automation trends.
RFK Jr to Be Fired? - Ad
On October 7, six former US Surgeon Generals published a letter trying to get RFK Jr. fired. Most of them have direct ties to the $1.7 TRILLION pharmaceutical industry. It makes you wonder... What are they all so darn worried about?
Prescription drug coverage options are shrinking for Medicare shoppers
Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall.
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed.
Robert F. Kennedy Jr BOMBSHELL - Ad
Have you seen THIS shocking RFK Jr story? The corrupt mainstream media won't dare breathe a word about it... Yet this controversy is harming the brains of millions of Americans aged 65+...
Mark Cuban on Selling Mavericks Stake: 'I Don't Want My Kids Feeling Pressure To Walk Into My Spot As Owner And Try To Deal With That'
Earlier this year entrepreneur Mark Cuban relinquished his majority stake in the Dallas Mavericks, marking the end of his 23-year reign as the team's principal owner.
Congressman Misses Out On 67% Intel Gains, 100K Federal Workers To Resign And More: This Week In Politics
Donald Trump's recent actions are driving major developments in federal employment, the EV market, nuclear energy, and rare earth investments.
Shocking Elon Move: Bigger Than DOGE? - Ad
After blowing everyone's mind with his recent DOGE moves, what Elon Musk is about to do next will not only shock the world... But it could also put an extra $30,000 a year in your pocket.
Penguin Solutions Q4 Preview: Modest Beat Likely, Analyst Raises Price Target
Penguin Solutions expected to beat estimates in Q4 due to strong memory demand, according to Rosenblatt analyst. Price target raised.
Government shutdown enters fifth day as Democrats and Republicans remain at an impasse
WASHINGTON (AP) — Republican and Democratic lawmakers at an impasse on reopening the provided few public signs Sunday of meaningful negotiations talking place to end what has so far been a five-day shutdown.
A Worldwide Gold Lockdown Is Now Underway - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Stock Of The Day: Is SoFi Forming A New Range?
SoFi Technologies appears to be forming a new range. Some traders will buy at the bottom and try to sell at the top.
News stories show that reporters may have left the Pentagon, but they haven't stopped working
Two days after dozens of journalists at the Pentagon behind rather than agree to government-imposed rules on how they report about the U.S. military, it's apparent they haven't stopped working.
Released: Manhattan Project's Cancer Breakthrough - Ad
The Manhattan Project, the greatest scientific endeavor of the 20th Century, led to a cancer breakthrough from its research. This Nobel Prize-winning discovery helps stop cancer in its tracks-Naturally, safely, and without chemo.
Retail Investors Gain Access To Private Credit Market Via This New ETF
Simplify Asset Management and VettaFi have introduced a new exchange-traded fund (ETF) that enables retail investors to tap into the rapidly growing private credit market.
British department store Harrods warns customers that some personal details taken in data breach
LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.
New Moon Landing Conspiracy Exposed - Ad
NASA wants you to wonder if the moon landing even happened; anything to avoid answering THIS. It's not whether they did it - it's what they found once they got there.
CSX railroad replaces CEO after investor pressure and poor performance as Union Pacific merger looms
CSX railroad announced Monday that it had replaced its CEO less than two months after an investment fund urged it to either to better compete with the proposed railroad or fire outgoing CEO Joe Hinrichs.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.